Blair William & CO Glaukos Corp Transaction History

Blair William & CO

$32 Billion
Q2 2024

A detailed history of Blair William & CO transactions in Glaukos Corp stock. As of the latest transaction made, Blair William & CO holds 49,094 shares of GKOS stock, worth $6.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

49,094

Previous 49,990 1.79%

Holding current value

$6.9 Million

Previous $4.71 Million 23.28%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$89.48 - $118.35 $80,174 - $106,041	-896 Reduced 1.79%	49,094 $5.81 Million
Q1 2024 May 09, 2024	BUY	$76.4 - $96.33 $218,733 - $275,792	2,863 Added 6.08%	49,990 $4.71 Million
Q4 2023 Feb 12, 2024	SELL	$59.53 - $85.11 $564,642 - $807,268	-9,485 Reduced 16.75%	47,127 $3.75 Million
Q3 2023 Nov 09, 2023	BUY	$69.23 - $79.09 $2.97 Million - $3.4 Million	42,946 Added 314.25%	56,612 $4.26 Million
Q2 2023 Aug 11, 2023	BUY	$45.44 - $71.21 $4,544 - $7,120	100 Added 0.74%	13,666 $973,000
Q1 2023 May 12, 2023	BUY	$43.88 - $52.48 $1,930 - $2,309	44 Added 0.33%	13,566 $679,000
Q3 2022 Nov 09, 2022	SELL	$46.84 - $58.49 $473,786 - $591,626	-10,115 Reduced 42.79%	13,522 $720,000
Q2 2022 Aug 10, 2022	SELL	$34.86 - $63.77 $1,045 - $1,913	-30 Reduced 0.13%	23,637 $1.07 Million
Q1 2022 May 13, 2022	SELL	$44.33 - $57.82 $12,412 - $16,189	-280 Reduced 1.17%	23,667 $1.37 Million
Q4 2021 Feb 14, 2022	SELL	$40.27 - $56.99 $576,666 - $816,096	-14,320 Reduced 37.42%	23,947 $1.06 Million
Q3 2021 Nov 12, 2021	BUY	$47.43 - $84.23 $493,366 - $876,160	10,402 Added 37.33%	38,267 $1.84 Million
Q2 2021 Aug 12, 2021	SELL	$73.06 - $97.7 $66,265 - $88,613	-907 Reduced 3.15%	27,865 $2.36 Million
Q1 2021 May 13, 2021	SELL	$70.43 - $97.42 $288,129 - $398,545	-4,091 Reduced 12.45%	28,772 $2.42 Million
Q4 2020 Feb 09, 2021	SELL	$48.9 - $75.26 $443,082 - $681,930	-9,061 Reduced 21.61%	32,863 $2.47 Million
Q3 2020 Nov 06, 2020	SELL	$37.23 - $50.97 $200,260 - $274,167	-5,379 Reduced 11.37%	41,924 $2.08 Million
Q2 2020 Aug 12, 2020	SELL	$28.78 - $46.83 $263,279 - $428,400	-9,148 Reduced 16.21%	47,303 $1.82 Million
Q1 2020 May 11, 2020	SELL	$25.53 - $70.14 $732,276 - $2.01 Million	-28,683 Reduced 33.69%	56,451 $1.74 Million
Q4 2019 Feb 13, 2020	BUY	$54.18 - $65.64 $701,305 - $849,644	12,944 Added 17.93%	85,134 $4.64 Million
Q3 2019 Nov 12, 2019	BUY	$58.58 - $83.91 $2.69 Million - $3.86 Million	45,975 Added 175.38%	72,190 $4.51 Million
Q2 2019 Aug 13, 2019	SELL	$63.59 - $78.71 $422,110 - $522,476	-6,638 Reduced 20.21%	26,215 $1.98 Million
Q1 2019 May 14, 2019	BUY	$50.75 - $80.54 $144,028 - $228,572	2,838 Added 9.46%	32,853 $2.58 Million
Q4 2018 Feb 14, 2019	BUY	$52.18 - $67.93 $171,411 - $223,150	3,285 Added 12.29%	30,015 $1.69 Million
Q3 2018 Nov 13, 2018	SELL	$38.13 - $68.37 $37,367 - $67,002	-980 Reduced 3.54%	26,730 $1.74 Million
Q2 2018 Aug 13, 2018	SELL	$27.62 - $44.51 $1.59 Million - $2.57 Million	-57,653 Reduced 67.54%	27,710 $1.13 Million
Q1 2018 May 15, 2018	SELL	$26.05 - $34.5 $134,886 - $178,641	-5,178 Reduced 5.72%	85,363 $2.63 Million
Q4 2017 Feb 14, 2018	SELL	$24.5 - $36.01 $652,753 - $959,414	-26,643 Reduced 22.74%	90,541 $2.32 Million
Q3 2017 Nov 13, 2017	BUY	$31.26 - $42.03 $3.66 Million - $4.93 Million	117,184	117,184 $3.87 Million

Others Institutions Holding GKOS

# of Institutions

310

Shares Held

46.8M

Call Options Held

75.3K

Put Options Held

157K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.69B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account